News

#Business #Drug development #Drug discovery #Genetics / genomes #Immunology #Oncology #Therapeutics

Horizon Discovery licenses platform to TrueBinding for biotherapeutics development

TrueBinding, a biopharmaceutical company, has signed a set of commercial licenses for Horizon Discovery’s CHOSOURCE platform. TrueBinding will use the cGMP-compliant platform for the development and commercialisation of multiple biotherapeutic products for applications in immuno-oncology and other disease areas with great unmet medical need. Horizon’s CHOSOURCE platform includes a gene-edited… Read More

#News

#Drug development #Drug discovery #Imaging #Lead discovery #QA/QC #RNA #Screening

NanoImaging Services opens West Coast facility to help grow of its CryoEM network

NanoImaging Services, has opened a new facility close to its San Diego headquarters. The new data collection centre will be the largest private facility for cryoEM data collection globally, says the company, and will serve both national and international clients. Designed to be a data collection farm, this… Read More

#News

#Cell therapy #Clinical trials #Gene therapy #Oncology #Preclinical

Collaboration to investigate IMM-101 in difficult to treat cancers

This will explore clinical trials with IMM-101, in combination with other treatments, in difficult to treat cancers, with a particular focus on epithelial cancers such as pancreatic cancer and sarcoma. Immodulon, an immuno-oncology company, and the Champalimaud Foundation, a private, non-profit, research organisation in Lisbon, Portugal, have announced… Read More

#Cancer Research #News

#Oncology

ASCO 2020 Virtual Education Program

Now being held virtually, the upcoming ASCO20 Virtual Education Program, will provide 90 sessions covering topics in cancer education, updates in cancer treatment, professional development, COVID-19, and more. ASCO 2020 Virtual Education Program Now being held virtually, the upcoming ASCO20 Virtual Education Program, will provide 90 sessions covering… Read More

#Covid-19 #News

#Clinical trials #Drug development #Therapeutics

Parkinson’s UK backs NRG Therapeutics’ breakthrough drug development

Parkinson’s UK has invested an additional £1 million in NRG Therapeutics mitochondrial drug development programme. This funding boost, on top of an initial £1 million investment, will support the development of a breakthrough drug with the potential to slow or halt the progression of Parkinson’s – something no… Read More

#Covid-19 #News

#Immunology / Virology & Vaccines #Regulatory

Sanofi and GSK in discussions with EC to supply COVID-19 vaccine

Sanofi and GSK are in advanced discussions with the European Commission (EC) for the supply of up to 300 million doses of a COVID-19 vaccine. The vaccine candidate developed by Sanofi in partnership with GSK, is based on the recombinant protein-based technology used by Sanofi to produce an… Read More

#Covid-19 #News

#Analysis #Drug development #Drug discovery #Drug targets #Lead discovery #Regulatory #RNA

Analysis could find drug targets for attention deficits and sensory hypersensitivity

Image: Jesse Orrico Many people with autism experience sensory hypersensitivity, attention deficits and sleep disruption. One brain region implicated is the thalamic reticular nucleus (TRN), which is believed to act as a gatekeeper for sensory information flowing to the cortex, by Anne Trafton, MIT News Office A team… Read More

#News

#Cell therapy #Drug development #Drug discovery #Gene therapy #Genetics / genomes #Immunology #Regulatory #RNA #Stem cells

How the regulator is regulated: insight on immune-related protein holds therapeutic value

Image: National Cancer Institute Scientists unravel how the immune checkpoint protein PD-L2 is regulated, which has potential implications in immune therapy Various proteins expressed in cells of the immune system have shown to play an important role in various disorders, including cancer, allergy, and autoimmune disease. In a… Read More

#News

#Analysis #Drug development #Drug discovery #Genetics / genomics #Genomics #Oncology #RNA

Genetic study says iron levels could be key to ageing slowly

30 July 2020 Image: Sven Mieke Genes linked to ageing that could help explain why some people age at different rates to others have been identified by scientists. The international study using genetic data from more than a million people suggests that maintaining healthy levels of iron in… Read More

#News

#Academic #Biologics / Biotechnology #Business #Cellular assays #Clinical trials #Drug development #Drug discovery #Enabling technologies #Genomics #High Content Screening #High throughput screening #Imaging #Immunology #Microfluidics #Screening #Stem cells #Therapeutics #Translational #Translational chemistry

Just-Evotec Biologics to make monoclonal antibody products for COVID-19

Image: Ani Kolleshi The US Department of Defence (DOD) has awarded Evotec’s Seattle-based subsidiary, Just-Evotec Biologics a contract worth $18.2 million to develop monoclonal antibodies (mAbs) for treatment and/or prevention of COVID-19 Under the contract, Just–Evotec Biologics will design a manufacturing process for the production of Current Good… Read More

#Covid-19 #News

#Academic #Assay development optimisation & technology #Business #Cell therapy #Cellular assays #Chemical engineering #Clinical trials #Drug development #Drug discovery #Enabling technologies #Gene editing #Gene therapy #Genomics #High Content Screening #High throughput screening #Imaging #Lead discovery #Microfluidics #Oncology #RNA #Screening #Stem cells #Therapeutics #Toxicology #Translational #Translational chemistry

Merging two immunotherapies may be more effective treatment against some cancers

Some of the most promising advances in cancer treatment have centred on immunotherapies that rev up a patient’s immune system to attack cancer. However, immunotherapies don’t work in all patients, and researchers have been searching for ways to increase their effectiveness. Now, researchers at Washington University School of… Read More

#Cancer Research #News

#Cell therapy #Drug development #Drug discovery #Drug targets #Gene therapy #Lead discovery #Oncology #Preclinical #RNA #Stem cells

Researchers ID new target in drive to improve immunotherapy for head and neck cancer

Researchers at the UCLA Jonsson Comprehensive Cancer Center and UCLA School of Dentistry have identified a potential new combination therapy to treat advanced head and neck squamous cell carcinoma, the most common type of head and neck cancer. A study in mice found that using an anti-PD1 immunotherapy… Read More

#Cancer Research #News

#Analysis #Business #Cell therapy #Clinical trials #Drug development #Drug discovery #Gene therapy #High throughput screening #Imaging #Mass spectrometry / NMR #Microbiology #Screening #System biology #Target validation

Avacta updates on clinical validation of Adeptrix COVID-19 diagnostic test

Image: Pille-Riin Priske Avacta has begun work with the UK government’s CONDOR programme to evaluate and clinically validate the high throughput COVID-19 bead-assisted mass spectrometry (BAMS) laboratory assay developed with Adeptrix. The COVID-19 National Diagnostic Research and Evaluation Platform (CONDOR), recently funded by the National Institute for Health… Read More

#Covid-19 #News

#Academic #Assay development optimisation & technology #Business #Cellular assays #Drug development #Drug discovery #Enabling technologies #Gene editing #Genomics #High Content Screening #High throughput screening #Imaging #Lead discovery #Microfluidics #Precision medicine #Preclinical #Screening #Stem cells #Therapeutics #Translational #Translational chemistry

British Patient Capital invests in life-changing biotech companies

British Patient Capital is committing $65m to SV Health Investors’ latest fund, SV7 Impact Medicine Fund (IMF), to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases. The commitment increases British Patient Capital’s exposure to life sciences and health technology, building… Read More

#Covid-19 #News

#Genomics #Lead discovery #Precision medicine #Protein chemistry / Proteomics

Biopharma R&D interest in quantum computing due to efficiency and effectiveness benefits

27 July 2020 Image: Michael Dziedzic New survey results from the Pistoia Alliance, the Quantum Economic Development Consortium (QED-C) and QuPharm show almost one third of life science organisations polled are set to begin quantum computing evaluation this year. A further 39% are planning to evaluate next year… Read More

#News

#Business #Drug development #Drug discovery #Enabling technologies #Immunology #Immunology / Virology & Vaccines #Lead discovery #Regulatory #RNA #Stem cells

GSK and CureVac in mRNA technology collaboration

27 July 2020 Image: CDC GlaxoSmithKline and CureVac are collaborating for the research, development, manufacturing and commercialisation of up to five mRNA-based vaccines and monoclonal antibodies (mAbs) targeting infectious disease pathogens. The collaboration complements GSK’s existing mRNA capabilities with CureVac’s integrated mRNA platform. mRNA (messenger RNA) technology is… Read More

#News